BioLINCC
The Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC) facilitates and coordinates the NHLBI Biorepository and the Data Repository activities. BioLINCC aims to enable access to and maximize the scientific value of biospecimen and clinical data resources collected by clinical trials and observational studies supported by the Institute.
Furthermore, BioLINCC promotes the use of and facilitates access to biospecimen and clinical data resources through a single web-based user interface and enhances and facilitates further research in cardiovascular, hematologic, and pulmonary conditions by providing qualified investigators access to stored biospecimen and data collections.
- Estimating the risk of type-2 diabetes using obese-years in a contemporary population of the Framingham Study
- Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction
- Effects of differential measurement error in self-reported diet in longitudinal lifestyle intervention studies
- Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays
- Time-dependent mediators in survival analysis: Modeling direct and indirect effects with the additive hazards model
- Diagnostic Instability and Reversals of Chronic Obstructive Pulmonary Disease Diagnosis in Individuals with Mild to Moderate Airflow Obstruction
- Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial
- Estimating the risk of cardiovascular disease using an obese-years metric
- Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study
- Efficacy and safety of digoxin in patients with heart failure and reduced ejection fraction according to diabetes status: An analysis of the Digitalis Investigation Group (DIG) trial
More information about BioLINCC can be found at https://biolincc.nhlbi.nih.gov/home/
To access BioLINCC data, visit Teaching Datasets - Public Use Datasets